Pursuant to the provisions of Regulation 30 of the SEBI LODR, Indo National has informed that the Board of Directors of the Company has, at its meeting held on 16th April 2025, approved the execution of: (i) a Share Subscription Agreement; and (ii) a Shareholders' Agreement, with Medcuore medical solutions (‘MMSPL’) and its promoters (‘Transaction Documents’), for the purpose of an investment of INR 17,00,00,000 over a period of three financial years including current financial year by way of subscription to Equity Shares of MMSPL, which constitutes 70.70% of the paid-up share capital of (‘MMSPL’) on a fully diluted basis, subject to the fulfilment of certain identified conditions precedent and closing of the transaction documents (‘Proposed Transaction’). The disclosure required under Regulation 30(4) of the SEBI LODR read with the Disclosure Circular, is enclosed as Annexure-A. The Board meeting commenced at 9.00 am and concluded at 11.00 am.
The above information is a part of company’s filings submitted to BSE.
